Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
about
Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologiesNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayNovel algorithm for non-invasive assessment of fibrosis in NAFLDNIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLDNoninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Non invasive tools for the diagnosis of liver cirrhosis.MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.Non-invasive markers for hepatic fibrosisTime-dependent network analysis reveals molecular targets underlying the development of diet-induced obesity and non-alcoholic steatohepatitis.Nonalcoholic fatty liver disease: Diagnostic biomarkers.Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children.Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and realityIs there a place for serum laminin determination in patients with liver disease and cancer?Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects?Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.Plumbagin Alleviates Capillarization of Hepatic Sinusoids In Vitro by Downregulating ET-1, VEGF, LN, and Type IV Collagen.Non-invasive assessment of liver fibrosis.Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers.Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.Liver abnormalities and post-transplant survival in pediatric Fontan patients.Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action.Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.Noninvasive Biomarkers of Liver Fibrosis: An Overview
P2860
Q26752723-6F444357-491D-4DF5-A49C-C0581077C8EAQ26800894-44B61C37-5A4D-4350-B95C-25F2D19F837DQ28289982-2192814B-4D73-4C69-A9B8-F15D970F4024Q28488938-9AF29E82-2502-41EE-A0B4-FB68E76B5BF3Q30355082-6AB83E82-CE7E-45A7-8DDE-953E1F04F330Q30421450-C62063FF-1FFC-417A-8016-62B4C5126C25Q30439971-C9A12C96-CF02-44F1-887F-BA81A1F7F9D7Q30464608-F46E38FA-B0EE-4D52-990B-8D444F6CEF38Q30474093-E1F43DFB-9724-432E-82D9-C11FF1E80F93Q30539316-BE0156F9-4CC9-4A92-8C31-9F77193F6419Q33706254-4B5CBDC2-52E0-4518-A9EE-99EE13BCB44CQ34256132-F2EADA62-D937-4A15-9288-AA28E8867E89Q36428863-5667B0AC-FEDE-4B88-8DB7-F45C96F66BF3Q36591048-1C09BA61-64A3-4472-B843-451ED2EF60D2Q36990696-5E70D767-64C8-4960-8BF0-DC5E208D0788Q37205152-6E37953F-5B19-4778-8357-9A06C39FBCC4Q37850490-488BC0EE-F658-48F0-9E83-393A44320A20Q38066240-232BD612-2BC9-4AD4-A5DC-5EF61FD9BE65Q39840925-BDDA44B1-BCBB-4ECE-9A4F-D733A22861ABQ41100086-E56142B0-F34C-41E9-859A-C496D052E246Q42406716-E2BC59C4-0EEB-412B-A6B2-2A328F9D4660Q43056949-92358EFD-D7FA-4252-8BD4-063CE7545A55Q46537986-FF5F0161-857F-489A-9709-F62ECD9948E2Q46636339-2A1A07BF-BB58-4451-9664-2CFDB9563B93Q48362509-EA606E6E-9B57-4A70-B9E4-6AF0E102C8A3Q51271391-F90DAEB9-45E2-4345-BCC8-641C3CE74B00Q52619982-7CEB28BC-3134-4CEE-B027-90589C7687BBQ59050387-601EA05A-914C-4575-A4D0-47D6EA4F29D3
P2860
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
@en
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
@nl
type
label
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
@en
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
@nl
prefLabel
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
@en
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
@nl
P2093
P2860
P1433
P1476
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
@en
P2093
Eyaggelia Kostadelou
Helen Lydatakis
Ieronymos Philippos Hager
Ioannis Diamantis
Stavros Mpousmpoulas
Stavros Pappas
P2860
P304
P356
10.1111/J.1478-3231.2006.01312.X
P577
2006-09-01T00:00:00Z